HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CNMD
Conmed Corp
Healthcare Medical Devices · New York, USA · Reports in usd
Market Cap: $1.19B
Market Cap
$1.19B
Enterprise Val
$1.98B
P/E Ratio
25.23
P/B Ratio
1.15
Trailing PEG (1Y)
-0.50
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$1.03B
Gross Margin58.49%
Profit Margin58.49%
Return on Equity4.68%
Return on Assets2.03%
Current Ratio2.14
Debt/Equity0.81
LT Debt/Equity0.81
Revenue Per Share12.05

Income Statement

Dec 31, 2025
Revenue$373.2M
Cost of Revenue$154.9M
Gross Profit$218.3M
R&D$14.9M
SG&A$166.8M
Operating Expenses$181.7M
Operating Income$36.6M
Interest Expense$7.4M
Tax Expense$12.5M
Net Income$16.7M
EPS (Basic)$0.54
EPS (Diluted)$0.54
EBIT$36.6M
EBITDA$40.7M
Consolidated Income$16.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$40.8M
Accounts Receivable$247.8M
Inventory$355.5M
Current Assets$672.9M
LT Investments$0.00
Property, Plant & Equipment$113.3M
Intangibles$1.39B
Non-Current Assets$1.65B
Total Assets$2.33B
Accounts Payable$93.6M
Current Debt$712.0K
Current Liabilities$315.0M
LT Debt$834.2M
Non-Current Liabilities$977.6M
Total Liabilities$1.29B
Total Debt$834.9M
Retained Earnings$588.8M
Shareholder Equity$1.03B
Shares Outstanding30,967,954

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$46.3M
Investing Cash Flow-$7.1M
Financing Cash Flow-$37.4M
CapEx-$5.1M
Free Cash Flow$41.2M
Depreciation & Amort.$4.1M
Stock-Based Comp$5.0M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$20.0M
Equity Issued/Repaid$0.00
Dividends Paid-$6.2M
Net Change in Cash$1.9M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h